Measurement of the mortality rate of RPW third and fifth instar larvae after three and six days of exposure to three different dsRNAs. by Muhammad Naeem Sattar (19828497)

Schematic diagram of cyclic loading. by Xiangwu Luo (22138922)

“…Specimens underwent two-phase loading with controlled stress amplitude variations (increase, decrease, or maintenance) in the second stage. …”

Change^a in incidence of repetition according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Change^a in incidence of dropout according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Diachronic tendencies in the frequency of regionally differentiated radiocarbon dates per region. The percentage of dates for GI-1d-a (green dot, left side of the arrow) and GS-1 (... by Isabell Schmidt (6331013)

Table6_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table4_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table2_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table8_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table5_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table3_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table7_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.docx by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Table1_Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry.DOCX by J. Riera-Arnau (20431328)

“…In the sensitivity analysis, the A-level usage rate decreased to one-third and the B-level usage rate increased by 2–3 times. …”

Change^a in years of age at school entry according to a one-unit change in the initial value of the height-for-age z-score. by Rabi Joël Gansaonré (20416803)

Flow chart. by Raphaele Houlbracq (20558509)

“…We described the overall prevalence of outcomes, and then by obstetrical clinical contexts using a seven-group obstetric classification of women. …”

Flow chart describing samples. by Rabi Joël Gansaonré (20416803)

“…A third objective was to explore the relationship between stunting, grade repetition, and school dropout.…”

Oral infection with YFV-Asibi cap0 leads to lower viral loads in the midguts largely diminishing dissemination to secondary tissues. by Anja vom Hemdt (19787189)

Change^a in incidence of repetition [95% confidence interval]. by Rabi Joël Gansaonré (20416803)

Table 1_Efficacy of submucosal administration of tramadol on acute pain following third molar surgery: a systematic review and meta-analysis.docx by Ahmad Salem Assari (20277900)

“…In addition, tramadol demonstrated a significant decrease in post-operative pain.</p>Conclusion<p>Submucosal tramadol is an efficient, safe, and dependable method for reducing post-operative acute pain, particularly in the first 6 h following impacted third molar surgery. …”

Demographic and clinical characteristics of study sample (<i>N</i> = 1810). by Olivia Ojala (14057026)

Subjects: